What is Produodopa?
•
4 min read
In a 2022 Phase III clinical trial, continuous Produodopa treatment led to a significant increase in daily 'on' time for people with advanced Parkinson's disease. **What is Produodopa?** It is an innovative, continuous-infusion therapy designed to manage severe motor fluctuations that are no longer adequately controlled by oral medications.
